Prieur, A., Harper, A., Khan, M., Vire, B., Joubert, D., Payen, L., & Kopciuk, K. (2023). Plasma hPG80 (Circulating Progastrin) as a Novel Prognostic Biomarker for early-stage breast cancer in a breast cancer cohort. BMC Cancer, 23(1), 1. https://doi.org/10.1186/s12885-023-10729-1
Chicago Style (17th ed.) CitationPrieur, Alexandre, Andrew Harper, Momtafin Khan, Bérengère Vire, Dominique Joubert, Léa Payen, and Karen Kopciuk. "Plasma HPG80 (Circulating Progastrin) as a Novel Prognostic Biomarker for Early-stage Breast Cancer in a Breast Cancer Cohort." BMC Cancer 23, no. 1 (2023): 1. https://doi.org/10.1186/s12885-023-10729-1.
MLA (9th ed.) CitationPrieur, Alexandre, et al. "Plasma HPG80 (Circulating Progastrin) as a Novel Prognostic Biomarker for Early-stage Breast Cancer in a Breast Cancer Cohort." BMC Cancer, vol. 23, no. 1, 2023, p. 1, https://doi.org/10.1186/s12885-023-10729-1.